VSCP: Summary for VirtualScopics, Inc. - Yahoo! Canada Finance

	Sign In [New User? Sign Up]	Finance Home \|Help

Wednesday, February 10, 2010, 6:20am EST - Canadian Markets open in 3 hours and 10 minutes.

To create a watchlist or portfolio of shares, Sign-in or Register

VirtualScopics Inc. (VSCP)

On Feb 9: 1.08 USD 0.00 (0.00%)

MORE ON VSCP

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

VirtualScopics, Inc. (NCM:VSCP) Delayed quote data

Last Trade:	1.08 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	1.08
Open:	N/A
Bid:	N/A
Ask:	1.56 x 1000
1y Target Est:	3.00

Day's Range:	N/A - N/A
52wk Range:	0.59 - 1.95
Volume:	0
Avg Vol (3m):	53,607.9
Market Cap:	26.89M
P/E (ttm):	N/A
EPS (ttm):	-0.16
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y

Add VSCP to Portfolio

Download Data

HEADLINES

•	VirtualScopics Reports Significant Revenue Growth and Cash Flow for 2009
	PRNewswire (Tue 10:00am)

•	VirtualScopics' Project Balance Hits New Record Level
	PRNewswire (Thu, Feb 4)

•	VirtualScopics Schedules Fourth Quarter/Full Year 2009 Earnings Announcement
	PRNewswire (Tue, Feb 2)

•	VirtualScopics to Present at the 12th Annual BIO CEO & Investor Conference
	PRNewswire (Wed, Jan 27)

•	VirtualScopics to Present at the Upcoming OneMedPlace Investment Conference
	PRNewswire (Fri, Jan 8)

•	VirtualScopics Receives Issuance in Japan of Prominent Patent
	PRNewswire (Thu, Dec 3)

•	VIRTUALSCOPICS, INC. Financials
	EDGAR Online Financials (Thu, Nov 19)

•	VIRTUALSCOPICS, INC. Files SEC form 10-Q, Quarterly Report
	EDGAR Online (Fri, Nov 13)

•	VIRTUALSCOPICS, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhi
	EDGAR Online (Thu, Nov 12)

•	VirtualScopics, Inc. Reports Another Record Breaking Quarter Revenue Growth of 54%, Gross Profit Increases 97%, Net Operating Cash Flow Increases 207
	PRNewswire (Thu, Nov 12)

More Headlines for VSCP...

ANALYST

EPS Est (next year) (Dec-07) :	N/A
EPS Est (in 2 years) (Dec-08) :	N/A
Avg Rec (current)*:	2.0
PEG Ratio:	N/A

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

VirtualScopics, Inc. provides image-based biomarker solutions to the pharmaceutical, biotechnology, and medical device industries. Its image-based biomarker measurement and visualization software tools enable the measurement of minute changes that...

Full Company Profile

Add to Portfolio

Email to a Friend

•